AHB
CELG

Abner Herrman & Brock’s Celgene Corp CELG Stock Holding History

Abner Herrman & Brock’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,000
Closed -$298K – 136
2019
Q3 		$298K Hold
3,000
– – 0.04% 92
2019
Q2 		$277K Hold
3,000
– – 0.04% 95
2019
Q1 		$283K Buy
+3,000
New +$262K 0.04% 94
2018
Q4 		– Sell
-3,000
Closed -$268K – 140
2018
Q3 		$268K Sell
3,000
-100
-3% -$8.84K 0.04% 108
2018
Q2 		$246K Sell
3,100
-100
-3% -$8.3K 0.04% 113
2018
Q1 		$285K Sell
3,200
-56,843
-95% -$5.46M 0.05% 109
2017
Q4 		$6.27M Buy
60,043
+1,909
+3% +$215K 1.05% 37
2017
Q3 		$8.48M Buy
58,134
+5
+0% +$681 1.5% 28
2017
Q2 		$7.55M Buy
58,129
+83
+0.1% +$10.2K 1.43% 28
2017
Q1 		$7.22M Sell
58,046
-1,132
-2% -$135K 1.44% 31
2016
Q4 		$7.03M Sell
59,178
-30,147
-34% -$3.36M 1.48% 29
2016
Q3 		$9.34M Sell
89,325
-3,820
-4% -$413K 2.12% 16
2016
Q2 		$9.63M Sell
93,145
-2,153
-2% -$223K 2.24% 16
2016
Q1 		$9.54M Buy
95,298
+24,952
+35% +$2.57M 2.4% 14
2015
Q4 		$8.43M Buy
70,346
+10,420
+17% +$1.21M 4.34% 4
2015
Q3 		$7.01M Sell
59,926
-170
-0.3% -$21.1K 3.74% 5
2015
Q2 		$7.02M Buy
60,096
+70
+0.1% +$8K 3.52% 8
2015
Q1 		$6.92M Sell
60,026
-295
-0.5% -$35.3K 3.52% 6
2014
Q4 		$6.75M Sell
60,321
-38,516
-39% -$4.06M 3.42% 7
2014
Q3 		$9.37M Sell
98,837
-475
-0.5% -$42.9K 2.75% 8
2014
Q2 		$8.53M Buy
99,312
+1,920
+2% +$146K 2.58% 9
2014
Q1 		$6.8M Buy
97,392
+5,238
+6% +$415K 2.18% 16
2013
Q4 		$7.49M Buy
92,154
+43,570
+90% +$3.45M 2.66% 9
2013
Q3 		$3.74M Sell
48,584
-44,196
-48% -$3.1M 2.48% 10
2013
Q2 		$5.43M Buy
+92,780
New +$5.58M 2.3% 11

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Abner Herrman & Brock's CELG Position: Q4 2019 in Review

Abner Herrman & Brock sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,000 shares — an estimated $298K sold.

Abner Herrman & Brock first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $9.63M in Q2 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Abner Herrman & Brock reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Abner Herrman & Brock sold 3,000 Celgene Corp shares in Q4 2019, an estimated $298K.
  • Abner Herrman & Brock first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Abner Herrman & Brock's Celgene Corp position peaked at $9.63M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Abner Herrman & Brock's 13F filing for Q4 2019, filed 10 Jan 2020.